Quantitative structure-activity relationships for estimating the aryl hydrocarbon receptor binding affinities of resveratrol derivatives and the antioxidant activities of hydroxystilbenes

Medicinal Chemistry Research

Volumn 19, Issue 8, 2010, Pages 864-901

  Rayne, Sierra ^a,b   Goss, Charles D ^a   Forest, Kaya ^c   Friesen, Ken J ^a  

^a UNIVERSITY OF WINNIPEG   (Canada)

^b Ecologica Research   (Canada)

^c OKANAGAN UNIVERSITY COLLEGE   (Canada)

Author keywords

Antioxidant activity; Aryl hydrocarbon receptor; Binding affinity; Hydroxystilbenes; Quantitative structure activity relationships; Resveratrol derivatives; Stilbenes

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; HYDROXYSTILBENE DERIVATIVE; RESVERATROL; RESVERATROL DERIVATIVE; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; BINDING AFFINITY; COMPUTER PROGRAM; CONFORMATIONAL TRANSITION; DISSOCIATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ELECTRIC POTENTIAL; ENERGY; ENTHALPY; IONIZATION; ISOMERISM; MOLECULAR MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STOICHIOMETRY;

EID: 78650724868     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-009-9236-2     Document Type: Article

References (80)

1. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24:2783-2840
2. Amorati R, Lucarini M, Mugnaini V, Pedulli GF, Roberti M, Pizzirani D (2004) Antioxidant activity of hydroxystilbene derivatives in homogeneous solution. J Org Chem 69:7101-7107
3. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL (2007) Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224:274-283
4. Baur JA, Sinclair DA (2006) Therapeutical potential of resveratrol: the in vivo evidence. Nature Rev Drug Discov 5:493-506
5. Becke AD (1993) Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys 98:5648-5652
6. Bendel RB, Afifi AA (1977) Comparison of stopping rule in forward stepwise regression. J Am Statist Assoc 72:46-53
7. Benitez D, Goddard WA (2005) The isomerization equilibrium between cis and trans chloride ruthenium olefin metathesis catalysts from quantum mechanics calculations. J Am Chem Soc 127:12218-12219
8. Bohme Leite T, Gomes D, Miteva M, Chomilier J, Villoutreix B, Tuffery P (2007) Frog: a free online drug 3D conformation generator. Nucl Acids Res 35:W568-W572
9. Cai Y, Wei Q, Fang J, Yang L, Liu Z, Wyche JH, Han Z (2004) The 3,4-dihydroxyl groups are important for trans-resveratrol analogs to exhibit enhanced antioxidant and apoptotic activities. Anticancer Res 24:999-1002
10. Cao J, Chen GH, Du YS, Hou FF, Tian YL (2006) Determination of dissociation constants of resveratrol and polydatin by capillary zone electrophoresis. J Liquid Chromatogr Relat Technol 29:1457-1463
11. Casper RF, Quesne M, Rogers IM, Shirota T, Jolivet A, Milgrom E, Savouret JF (1999) Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol 56:784-790
12. Cheng Z, Ren J, Li Y, Chang W, Chen Z (2002) Study on the multiple mechanisms underlying the reaction between hydroxyl radical and phenolic compounds by qualitative structure and activity relationship. Bioorg Med Chem 10:4067-4073
13. Cheng J, Fang J, Chen W, Zhou B, Yang L, Liu Z (2006) Structure-activity relationship studies of resveratrol and its analogues by the reaction kinetics of low density lipoprotein peroxidation. Bioorg Chem 34:142-157
14. Ciolino HP, Yeh GC (1999) Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 56:760-767
15. Ciolino HP, Daschner PJ, Yeh GC (1998) Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res 58:5707-5712
16. de la Lastra CA, Villegas I (2005) Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res 49:405-430
17. de la Lastra CA, Villegas I (2007) Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 35:1156-1160
18. de Medina P, Casper R, Savouret J, Poirot M (2005) Synthesis and biological properties of new stilbene derivatives of resveratrol as new selective aryl hydrocarbon modulators. J Med Chem 48:287-291
19. Dearden JC, Cronin MTD, Kaiser KLE (2009) How not to develop a quantitative structure-activity or structure-property relationship (QSAR/QSPR). SAR QSAR Environ Res 20:241-266
20. Dogra SK (2009) Cross-validation. QSARWorld-A Strand Life Sciences Web Resource, http://www.qsarworld.com/qsar-ml-cross-validation.php. Accessed 20 May 2009
21. Estevez L, Mosquera RA (2008) Molecular structure and antioxidant properties of delphinidin. J Phys Chem A 112:10614-10623
22. Fang J, Zhou B (2008) Structure-activity relationship and mechanism of the tocopherol-regenerating activity of resveratrol and its analogues. J Agric Food Chem 56:11458-11463
23. Fang J, Lu M, Chen Z, Zhu H, Li Y, Yang L, Wu L, Liu Z (2002) Antioxidant effects of resveratrol and its analogues against the free-radical-induced peroxidation of linoleic acid in micelles. Chemistry Eur J 8:4191-4198
24. Ferre-Filmon K, Delaude L, Demonceau A, Noels A (2004) Catalytic methods for the synthesis of stilbenes with an emphasis on their phytoalexins. Coord Chem Rev 248:2323-2336
25. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H et al (2004) Gaussian 03, revision C.02. Gaussian, Inc, Wallingford
26. Galeano Diaz T, Duran Meras I, Airado Rodriguez D (2007) Determination of resveratrol in wine by photochemically induced second-derivative fluorescence coupled with liquid-liquid extraction. Anal Bioanal Chem 387:1999-2007
27. Gokaraju GR, Gokaraju RR, Gottumukkala VS, Somepalli V (2002) Resveratrol Analogs. United States Patent 7,026,518 B2. Issued 11 April 2006
28. Guerrero RF, Garcia-Parrilla MC, Puertas B, Cantos-Villar E (2009) Wine, resveratrol and health: a review. Nat Prod Commun 4:635-658
29. Guiso M, Marra C, Farina A (2002) A new efficient resveratrol synthesis. Tetrahedron 43:597-598
30. Gupta S, Matthew S, Abreu PM, Aires-de-Sousa J (2006) QSAR analysis of phenolic antioxidants using MOLMAP descriptors of local properties. Bioorg Med Chem 14:1199-1206
31. Hansch C, Leo A, Taft R (1991) A survey of Hammett substituent constants and resonance and field parameters. Chem Rev 91:185-195
32. Hariharan PC, Pople JA (1972) The effect of d-functions on molecular orbital energies for hydrocarbons. Chem Phys Lett 16:217-219
33. Hehre WJ, Ditchfield R, Pople JA (1972) Self-consistent molecular orbital methods. XII. Further extensions of gaussian-type basis sets for use in molecular orbital studies of organic molecules. J Chem Phys 56:2257-2261
34. Herraez A (2006) Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Ed 34:255-261
35. Hilal SH, Karickhoff SW, Carreira LA (1995) A rigorous test for SPARC's chemical reactivity models: estimation of more than 4300 ionization pKas. Quant Struc Act Relat 14:348-355
36. Hilal SH, Saravanaraj AN, Whiteside T, Carreira LA (2007) Calculating physical properties of organic compounds for environmental modeling from molecular structure. J Comput Aided Mol Des 21:693-708
37. Jeffery T, Ferber B (2003) One-pot palladium-catalyzed highly chemo-, regio-, and stereoselective synthesis of trans-stilbene derivatives: a concise and convenient synthesis of resveratrol. Tet Lett 44:193-197
38. Joseph JA, Fisher DR, Cheng V, Rimando AM, Shukitt-Hale B (2008) Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging. J Agric Food Chem 56:10544-10551
39. Karacabey E, Mazza G (2008) Optimization of solid-liquid extraction of resveratrol and other phenolic compounds from milled grape canes (Vitis vinifera). J Agric Food Chem 56:6318-6325
40. Khlebnikov AI, Schepetkin IA, Domina NG, Kirpotina LN, Quinn MT (2007) Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems. Bioorg Med Chem 15:1749-1770
41. Klamt A, Schuumann G (1993) COSMO: a new approach to dielectric screening in solvents with explicit expressions for the screening energy and its gradient. J Chem Soc Perkin Trans 2:799-805
42. Langcake P (1981) Disease resistance of Vitis spp. and the production of the stress metabolites resveratrol, epsilon-viniferin, alpha-viniferin, and pterostilbene. Physiol Plant Pathol 18:213-226
43. Langcake P, Pryce R (1976) The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol Plant Pathol 9:77-86
44. Lee C, Yang W, Parr RG (1988) Development of the Colle-Salvetti correlation energy formula into a functional of the electron density. Phys Rev B 37:785-789
45. Lien EJ, Ren S, Bui HH, Wang R (1999) Quantitative structure-activity relationship analysis of phenolic antioxidants. Free Radic Biol Med 26:285-294
46. Lopez-Nicolas JM, Garcia-Carmona F (2008) Aggregation state and pKa values of (E)-resveratrol as determined by fluorescence spectroscopy and UV-visible absorption. J Agric Food Chem 56:7600-7605
47. Mayer JM, Rhile IJ (2004) Thermodynamics and kinetics of proton-coupled electron transfer: stepwise vs. concerted pathways. Biochim Biophys Acta 1655:51-58
48. McMahon B, Hanson RM (2008) A toolkit for publishing enhanced figures. J Appl Crystallogr 41:811-814
49. Migliavacca E, Carrupt PA, Testa B (1997) Theoretical parameters to characterize antioxidants. Part 1. The case of vitamin E and analogs. Helv Chim Acta 80:1613-1626
50. Murias M, Jager W, Handler N, Erker T, Horvath Z, Szekeres T, Nohl H, Gille L (2005) Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochem Pharmacol 69:903-912
51. Musialik M, Litwinienko G (2005) Scavenging of DPPH radicals by vitamin E is accelerated by its partial ionization: the role of sequential proton loss electron transfer. Org Lett 7:4951-4954
52. Nakanishi I, Kawashima T, Ohkubo K, Kanazawa H, Inami K, Mochizuki M, Fukuhara K, Okuda H, Ozawa T, Itoh S, Fukuzumi S, Ikota N (2005) Electron-transfer mechanism in radical-scavenging reactions by a vitamin E model in a protic medium. Org Biomol Chem 3:626-629
53. Nakanishi I, Shimada T, Ohkubo K, Manda S, Shimizu T, Urano S, Okuda H, Miyata N, Ozawa T, Anzai K, Fukuzumi S, Ikota N, Fukuhara K (2007) Involvement of electron transfer in the radicalscavenging reaction of resveratrol. Chem Lett 36:1276-1277
54. Ovesna Z, Horvathova-Kozics K (2005) Structure-activity relationship of trans-resveratrol and its analogues. Neoplasma 52:450-455
55. Pirola L, Frojdo S (2008) Resveratrol: one molecule, many targets. IUBMB Life 60:323-332
56. Piver B, Fer M, Vitrac X, Merillon J, Dreano Y, Berthou F, Lucas D (2004) Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochem Pharmacol 68:773-782
57. Potter GA, Patterson LH, Wanogho E, Perry PJ, Butler PC, Ijaz T, Ruparelia KC, Lamb JH, Farmer PB, Stanley LA, Burke MD (2002) The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br J Cancer 86:774-778
58. Puzyn T, Suzuki N, Haranczyk M, Rak J (2008) Calculation of quantum-mechanical descriptors for QSPR at the DFT level: is it necessary? J Chem Inf Model 48:1174-1180
59. Rassolov V, Pople JA, Ratner M, Redfern PC, Curtiss LA, Gbasis set for third-row atoms. J Comp Chem 22:976-984 (2001) 6-31.
60. Rastija V, Medic-Saric M (2009) QSAR study of antioxidant activity of wine polyphenols. Eur J Med Chem 44:400-408
61. Rayne S (2008) Grapevines (Vitis spp.) as components of the North American prairie biomass economy: high-value phytochemicals, platform chemicals, and bioenergy. Nat Prec http://precedings.nature.com/documents/2145/version/1
62. Rayne S, Karacabey E, Mazza G (2008) Grape cane waste as a source of trans-resveratrol and transviniferin: high-value phytochemicals with medicinal and anti-phytopathogenic applications. Ind Crop Prod 27:335-340
63. Remsberg CM, Yanez JA, Ohgami Y, Vega-Villa KR, Rimando AM, Davies NM (2008) Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytother Res 22:169-179
64. Revel A, Raanani H, Younglai E, Xu J, Han R, Savouret JF, Casper RF (2001) Resveratrol: a natural aryl hydrocarbon receptor antagonist, protects sperm from DNA damage and apoptosis caused by benzo(a)pyrene. Reprod Toxicol 15:479-486
65. Revel A, Raanani H, Younglai E, Xu J, Rogers I, Han R, Savouret J, Casper RF (2003) Resveratrol: a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J Appl Toxicol 23:255-261
66. Rossi M, Caruso F, Opazo C, Salciccioli J (2008) Crystal and molecular structure of piceatannol:scavenging features of resveratrol and piceatannol on hydroxyl and peroxyl radicals and docking with transthyretin. J Agric Food Chem 56:10557-10566
67. Savouret J, Quesne M (2002) Resveratrol and cancer: a review. Biomed Pharmacother 56:84-87
68. Shen T, Wang X, Lou H (2009) Natural stilbenes: an overview. Nat Prod Rep 26:916-935
69. Singh SU, Casper RF, Fritz PC, Sukhu B, Ganss B, Girard BJ, Savouret JF, Tenenbaum HC (2000) Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol. J Endocrinol 167:183-195
70. Stewart J (2007) Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements. J Mol Model 13:1173-1213
71. Stivala LA, Savio M, Carafoli F, Perucca P, Bianchi L, Maga G, Forti L, Pagnoni UM, Albini A, Prosperi E, Vannini V (2001) Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem 276:22586-22594
72. Stojanovic S, Sprinz H, Brede O (2001) Efficiency and mechanism of the antioxidant action of transresveratrol and its analogues in the radical liposome oxidation. Arch Biochem Biophys 391:79-89
73. Takagai Y, Kubota T, Kobayashi H, Tashiro T, Takahashi A, Igarashi S (2005) Adsorption and desorption properties of trans-resveratrol on cellulose cotton. Anal Sci 21:183-186
74. Tetko IV (2005) Computing chemistry on the web. Drug Discov Today 10:1497-1500
75. Tetko IV, Gasteiger J, Todeschini R, Mauri A, Livingstone D, Ertl P, Palyulin VA, Radchenko EV, Zefirov NS, Makarenko AS, Tanchuk VY, Prokopenko VV (2005) Virtual computational chemistry laboratory: design and description. J Comput Aided Mol Des 19:453-463
76. Tomiyama S, Sakai S, Nishiyama T, Yamada F (1993) Factors influencing the antioxidant activities of phenols by an ab initio study. Bull Chem Soc Japan 66:299-304
77. Tripathi T, Saxena A (2008) 2D-QSAR studies on new stilbene derivatives of resveratrol as a new selective aryl hydrocarbon receptor. Med Chem Res 17:212-218
78. Van Acker ABE, Koymans LMH, Bast A (1993) Molecular pharmacology of vitamin E: structural aspects of antioxidant activity. Free Rad Biol Med 15:311-328
79. Walle T, Hsieh F, DeLegge MH, Oatis JEJ, Walle UK (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:1377-1382
80. Waller CL, McKinney JD (1995) Three-dimensional quantitative structure-activity relationships of dioxins and dioxin-like compounds: model validation and Ah receptor characterization. Chem Res Toxicol 8:847-858